| 1 |
SIGMAR1
💬
| [2] Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Pathways of neurodegeneration - multiple diseases | Fenfluramine
Fenfluramine
💬
|
Fenfluramine
| [4] 140 140, 144, 145, 149 💬
|
| 2 |
SV2C
💬
| [1] ECM-receptor interaction ECM-receptor interaction | Padsevonil
Padsevonil
💬
|
Padsevonil
| [1] 149 149 💬
|
| 3 |
GABBR1
💬
| [7] cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Taste transduction, Estrogen signaling pathway, GnRH secretion, Morphine addiction | Baclofen
Baclofen
💬
|
Baclofen
| [8] 2 2, 10, 13, 18, 65, 70, 149, 206 💬
|
| 4 |
HTR1D
💬
| [4] cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction | Fenfluramine
Fenfluramine
💬
|
Fenfluramine
| [4] 140 140, 144, 145, 149 💬
|
| 5 |
HTR2A
💬
| [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels | Fenfluramine
Fenfluramine
💬
|
Fenfluramine
| [4] 140 140, 144, 145, 149 💬
|
| 6 |
HTR2C
💬
| [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels | Fenfluramine
Fenfluramine
💬
|
Fenfluramine
| [4] 140 140, 144, 145, 149 💬
|
| 7 |
SCN3A
💬
| [1] Taste transduction Taste transduction | Lacosamide
Lacosamide
💬
|
Lacosamide
| [4] 2 2, 46, 149, 298 💬
|
| 8 |
SCN9A
💬
| [1] Taste transduction Taste transduction | Lacosamide
Lacosamide
💬
|
Lacosamide
| [4] 2 2, 46, 149, 298 💬
|
| 9 |
SLC6A4
💬
| [2] Synaptic vesicle cycle Synaptic vesicle cycle, Serotonergic synapse | Fenfluramine
Fenfluramine
💬
|
Fenfluramine
| [4] 140 140, 144, 145, 149 💬
|
| 10 |
SNAP25
💬
| [2] Synaptic vesicle cycle Synaptic vesicle cycle, Insulin secretion | Botulinum toxin type A
Botulinum toxin type A
💬
|
Botulinum toxin type A
| [14] 2 2, 5, 6, 7, 13, 15, 17, 36, 47, 51, 70, 113, 149, 226 💬
|
| 11 |
CACNA1I
💬
| [7] MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | Flunarizine
Flunarizine
💬
|
Flunarizine
| [1] 149 149 💬
|
| 12 |
CACNA1H
💬
| [7] MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | Flunarizine
Flunarizine
💬
|
Flunarizine
| [1] 149 149 💬
|
| 13 |
CACNA1G
💬
| [8] MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome | Flunarizine
Flunarizine
💬
|
Flunarizine
| [1] 149 149 💬
|
| 14 |
GABBR2
💬
| [7] cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Taste transduction, Estrogen signaling pathway, GnRH secretion, Morphine addiction | Baclofen
Baclofen
💬
|
Baclofen
| [8] 2 2, 10, 13, 18, 65, 70, 149, 206 💬
|
| 15 |
SV2B
💬
| [1] ECM-receptor interaction ECM-receptor interaction | Padsevonil
Padsevonil
💬
|
Padsevonil
| [1] 149 149 💬
|
| 16 |
SV2A
💬
| [1] ECM-receptor interaction ECM-receptor interaction | Brivaracetam
Brivaracetam
💬
|
Brivaracetam
| [2] 149 149, 309 💬
|
| 17 |
SV2A
💬
| [1] ECM-receptor interaction ECM-receptor interaction | Padsevonil
Padsevonil
💬
|
Padsevonil
| [1] 149 149 💬
|